Amachiza kunye neSerotonin Syndrome

Ngokutsho kwe-US Food and Drug Administration, kukho ingozi eyongezelelekileyo ye- serotonin syndrome ngenxa yokudibanisa i-serotonin reuptake inhibitors (i-SSRIs) kunye ne-serotonin ekhethekileyo i-norepinephrine reuptake inhibitors i- SSNRIs ne-migraine ye-headache imithi ebizwa ngokuthi i-triptans.

I-Serotonin Reuptake Inhibitors (i-SSRIs)

Kukholelwa ukuba ingqondo iqulethe iindidi eziliqela ezihlukeneyo zezithunywa zamakhemikhali (i-neurotransmitters) ezisebenza njengama-intsebenziswano oonxibelelwano phakathi kweeseli ezahlukeneyo zobuchopho .

I-Serotonin yintsholongwane ebalulekileyo ekulawuleni imisebenzi eyahlukeneyo yomzimba kunye neemvakalelo. Amanqanaba e- serotonin aphantsi adibene nexinzelelo kunye nokuxhalabisa.

I-SSRI inqanda ukubuyiswa kwakhona kwe-serotonin kwingqondo. I-Reuptake yinkqubo apho i-neurotransmitters engqondweni ibuyiselwa kwakhona kwaye ikhutshwe okanye iphinde isetyenziswe ukusetyenziswa kwangaphambili. Oku kubangela ukwanda kwamanqanaba e-serotonin, okubangele ukuhlaziywa kwemizwa, ukunciphisa uxhalaba kunye nokuvinjelwa kwexhala . I-SSRI ithathwa njengonyango wokuqala kumnxeba wokuphazamiseka kwesifo kwaye iquka:

I-Serotonin-Norepinephrine Reuptake Inhibitors (SSNRIs)

I-SSNRI inqanda ukubuyiswa kwakhona kwe-serotonin kunye ne- norepinephrin ebuchosheni. I-Norepinephrine ngumthunywa weekhemikhali kwingqondo echaphazela ukulala nokuqapha. Kukholelwa ukuba iyahambelana nokuphendula uxinzelelo lokulwa-okanye-ukundiza .

SSNRI ziquka:

Triptans

I-Triptans yinkalo yeziyobisi ezisetyenziswa ngokuqhelekileyo ukuphatha unyango lwe-migraine okanye i-cluster headaches. Benza kwi-serotonin receptors kwingqondo, oko kuyachaphazela ama-serotonin.

Imizekelo yama-triptans iquka:

Ukongeza kwimiba echazwe kwi-advisory FDA, ezinye iziyobisi zihambelana nokuguqulwa kwamanqanaba e-serotonin ebuchosheni, okwandisa umngcipheko we-serotonin syndrome.

I-Tricyclic Antidepressants

I-Tricyclic antidepressants (TCAs) zithiwa ngamachiza '"amathathu atyhilo" isakhiwo seemodeli. Ngaphambi kokungeniswa kwe-SSRIs ekupheleni kweminyaka yama-1980, ii-TCA zazingumntu okhethekileyo kunyango lwengxaki enkulu yokuphazamiseka , ukuphazamiseka kwesifo kunye nezinye iingxaki zokuxhalabisa. Ii-TCAs zisetyenziselwa ukunyanga iintlungu ezithile zesifo kunye ne-enureis yasebusuku (i-bedwetting). Kukholelwa ukuba i-TCAs isebenze ukwandisa amanqanaba e-norepinephrin kunye ne-serotonin ebuchosheni.

Imizekelo yeTCA iquka:

I-Monoamine Oxidase Inhibitors (MAOIs)

I-MAOIs yiklasi le- anti-depressants believed to increase levels of norepinephrin, serotonin kunye ne-dopamine kwingqondo. Ziyasebenza ekwenzeni unyango olukhulu lwentlungu, ukuphazamiseka kwesifo kunye nezinye iingxaki zokuxhalabisa. Ngenxa yokubambisana okunobungozi kunye nokutya okuthile, iziyobisi kunye nezinye iziyobisi, ii-MAOI zidlalwa njengonyango lokugqibela lokunyanga.

Imizekelo ye-MAOI iquka:

Ezinye izixinzelelo

Imizekelo yezinye izidakamizwa ziquka:

Ezinye iiMicrocyatric Medication

Ii-Analgesics (Ubuhlungu Bokubulala)

I-Antibiotic / Antiretroviral Medication

Izidakamizwa / iziTyhulo zeDrama

Iidrama

Olu luhlu aluthethiwanga ukuba luhlanganiswe konke. Ukuze ugweme ukwandisa umngcipheko wokuphucula i-serotonin syndrome, xelela ugqirha wakho malunga nawo onke amayeza kunye nezondlo zokutya ozithathayo.

Ukuba uhlakulela iimpawu ze-serotonin syndrome, khangela uncedo lwezonyango.

Imithombo:

> Umtshini, uBetina C. "uSerotonin Syndrome." I-Journal ye-Neuroscience Nursing . Epreli 2006. 38 (2): 102-105.

> Ulawulo lweZiko lokuTya kunye neDrug. Ubomi-obunobungozi beSerotonin Syndrome kunye nokusetyenziswa okuhlanganisiweyo kwama-SSRIs okanye ama-SNRIs kunye neMilptan Medication. Julayi 19, 2006.